These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 4074196)

  • 1. Effects of fenofibrate on bile lipid composition.
    Palmer RH
    Arteriosclerosis; 1985; 5(6):631-8. PubMed ID: 4074196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of fenofibrate on biliary lipids and bile acid pool size in patients with type IV hyperlipoproteinemia.
    Podda M; Zuin M
    Atherosclerosis; 1985 May; 55(2):135-42. PubMed ID: 4004987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biliary lipid secretion in patients with heterozygous familial hypercholesterolemia and combined hyperlipidemia. Influence of bezafibrate and fenofibrate.
    Leiss O; Meyer-Krahmer K; von Bergmann K
    J Lipid Res; 1986 Jul; 27(7):713-23. PubMed ID: 3760707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of short-term treatment with bezafibrate and fenofibrate on biliary lipid metabolism in patients with hyperlipoproteinaemia.
    von Bergmann K; Leiss O
    Eur J Clin Invest; 1984 Apr; 14(2):150-4. PubMed ID: 6428905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of the effects of fenofibrate on lipoproteins, apoproteins, and bile saturation: US studies.
    Knopp RH
    Cardiology; 1989; 76 Suppl 1():14-22; discussion 29-32. PubMed ID: 2653621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of gemfibrozil administration on biliary lipid secretion in hyperlipidemic patients. A crossover study with clofibrate.
    Mazzella G; Bazzoli F; Villanova N; Simoni P; Festi D; Roda A; Aldini R; Roda E
    Scand J Gastroenterol; 1990 Dec; 25(12):1227-34. PubMed ID: 2274744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral contraceptives raise the cholesterol saturation of bile by increasing biliary cholesterol secretion.
    Bennion LJ; Mott DM; Howard BV
    Metabolism; 1980 Jan; 29(1):18-22. PubMed ID: 7351873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of fibric acid derivatives on biliary lipid composition.
    Palmer RH
    Am J Med; 1987 Nov; 83(5B):37-43. PubMed ID: 3318452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a salt of cholestyramine and 2-[4-(p-chlorobenzoyl)phenoxy]2-methyl propionic acid (alpha-1081) on biliary lipid secretion in rats.
    Aldini R; Barbara L; Benelli A; Borzatta V; Geminiani S; Mascellani G; Morselli A; Roda A; Roda E
    Br J Pharmacol; 1981 Nov; 74(3):611-7. PubMed ID: 6895340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of obesity and caloric intake on biliary lipid metabolism in man.
    Bennion LJ; Grundy SM
    J Clin Invest; 1975 Oct; 56(4):996-1011. PubMed ID: 1159099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary N-3 polyunsaturated fatty acids decrease biliary cholesterol saturation in gallstone disease.
    Berr F; Holl J; Jüngst D; Fischer S; Richter WO; Seifferth B; Paumgartner G
    Hepatology; 1992 Oct; 16(4):960-7. PubMed ID: 1398503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of ciprofibrate and fenofibrate on liver lipids and lipoprotein synthesis in normo- and hyperlipidemic rats.
    Petit D; Bonnefis MT; Rey C; Infante R
    Atherosclerosis; 1988 Dec; 74(3):215-25. PubMed ID: 3240333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of vitamin C in high doses on plasma and biliary lipid composition in patients with cholesterol gallstones: prolongation of the nucleation time.
    Gustafsson U; Wang FH; Axelson M; Kallner A; Sahlin S; Einarsson K
    Eur J Clin Invest; 1997 May; 27(5):387-91. PubMed ID: 9179545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the type of dietary fat on biliary lipid composition and bile lithogenicity in humans with cholesterol gallstone disease.
    Yago MD; González V; Serrano P; Calpena R; Martínez MA; Martínez-Victoria E; Mañas M
    Nutrition; 2005 Mar; 21(3):339-47. PubMed ID: 15797676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interrelationships of bile acid and phospholipid fatty acid species with cholesterol saturation of duodenal bile in health and gallstone disease.
    Berr F; Schreiber E; Frick U
    Hepatology; 1992 Jul; 16(1):71-81. PubMed ID: 1618485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of fenofibrate on plasma lipoproteins in hypercholesterolemia and combined hyperlipidemia.
    Knopp RH; Brown WV; Dujovne CA; Farquhar JW; Feldman EB; Goldberg AC; Grundy SM; Lasser NL; Mellies MJ; Palmer RH
    Am J Med; 1987 Nov; 83(5B):50-9. PubMed ID: 3318454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clofibrate treatment and bile cholesterol saturation: short-term and long-term effects and influence of combination with chenodeoxycholic acid.
    Angelin B; Einarsson K; Leijd B
    Eur J Clin Invest; 1981 Jun; 11(3):185-9. PubMed ID: 6791937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of biliary lipid secretion in non-obese cholesterol gallstone patients with normal, young, male volunteers.
    Leiss O; von Bergmann K
    Klin Wochenschr; 1985 Nov; 63(22):1163-9. PubMed ID: 4079281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma lipid concentrations and lecithin:cholesterol acyltransferase activity in normolipidemic subjects given fenofibrate and colestipol.
    Heller FR; Desager JP; Harvengt C
    Metabolism; 1981 Jan; 30(1):67-71. PubMed ID: 7464555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of loss of gallbladder function on biliary lipid composition in subjects with cholesterol gallstones.
    Redinger RN
    Gastroenterology; 1976 Sep; 71(3):470-4. PubMed ID: 950098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.